F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Liver fibrosis

Page 1 of 6 ( 267 items )
<<
1
2
3
4
5
6
>>

1	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 34 \| Download: 168
2	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 28 \| Download: 133
3	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 36 \| Download: 137
4	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 33 \| Download: 79
5	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 54 \| Download: 163
6	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 55 \| Download: 188
7	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 57 \| Download: 244
8	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 51 \| Download: 174
9	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 61 \| Download: 135
10	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 43 \| Download: 142
11	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 76 \| Download: 271
12	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 173 \| Download: 247
13	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 141 \| Download: 260
14	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 70 \| Download: 192
15	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 132 \| Download: 322
16	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 400 \| Download: 266
17	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 465 \| Download: 249
18	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 498 \| Download: 329
19	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 104 \| Download: 397
20	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 86 \| Download: 414
21	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 105 \| Download: 299
22	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 107 \| Download: 345
23	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 106 \| Download: 432
24	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 90 \| Download: 497
25	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 95 \| Download: 552
26	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 102 \| Download: 509
27	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 112 \| Download: 630
28	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 121 \| Download: 677
29	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 70 \| Download: 341
30	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 95 \| Download: 446
31	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 100 \| Download: 383
32	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 104 \| Download: 645
33	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 115 \| Download: 631
34	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 103 \| Download: 347
35	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 126 \| Download: 813
36	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 131 \| Download: 441
37	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 97 \| Download: 479
38	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 87 \| Download: 608
39	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 105 \| Download: 460
40	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 158 \| Download: 710
41	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 94 \| Download: 417
42	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 209 \| Download: 560
43	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 140 \| Download: 557
44	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 144 \| Download: 661
45	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 109 \| Download: 452
46	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 173 \| Download: 624
47	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 138 \| Download: 549
48	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 117 \| Download: 671
49	Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease 10/16/2024 6:29:25 AM \| Browse: 151 \| Download: 513
50	Elafibranor: A promising treatment for alcohol-associated liver disease? 10/12/2024 3:43:33 AM \| Browse: 146 \| Download: 576

Page 1 of 6 ( 267 items )
<<
1
2
3
4
5
6
>>

1	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 34 \| Download: 168
2	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 28 \| Download: 133
3	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 36 \| Download: 137
4	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 33 \| Download: 79
5	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 54 \| Download: 163
6	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 55 \| Download: 188
7	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 57 \| Download: 244
8	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 51 \| Download: 174
9	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 61 \| Download: 135
10	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 43 \| Download: 142
11	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 76 \| Download: 271
12	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 173 \| Download: 247
13	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 141 \| Download: 260
14	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 70 \| Download: 192
15	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 132 \| Download: 322
16	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 400 \| Download: 266
17	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 465 \| Download: 249
18	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 498 \| Download: 329
19	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 104 \| Download: 397
20	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 86 \| Download: 414
21	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 105 \| Download: 299
22	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 107 \| Download: 345
23	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 106 \| Download: 432
24	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 90 \| Download: 497
25	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 95 \| Download: 552
26	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 102 \| Download: 509
27	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 112 \| Download: 630
28	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 121 \| Download: 677
29	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 70 \| Download: 341
30	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 95 \| Download: 446
31	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 100 \| Download: 383
32	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 104 \| Download: 645
33	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 115 \| Download: 631
34	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 103 \| Download: 347
35	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 126 \| Download: 813
36	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 131 \| Download: 441
37	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 97 \| Download: 479
38	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 87 \| Download: 608
39	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 105 \| Download: 460
40	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 158 \| Download: 710
41	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 94 \| Download: 417
42	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 209 \| Download: 560
43	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 140 \| Download: 557
44	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 144 \| Download: 661
45	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 109 \| Download: 452
46	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 173 \| Download: 624
47	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 138 \| Download: 549
48	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 117 \| Download: 671
49	Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease 10/16/2024 6:29:25 AM \| Browse: 151 \| Download: 513
50	Elafibranor: A promising treatment for alcohol-associated liver disease? 10/12/2024 3:43:33 AM \| Browse: 146 \| Download: 576